The role of primary care in colorectal cancer screening: Experience from Czech Republic

Neoplasma

Volumn 55, Issue 1, 2008, Pages 74-80

  Seifert, B ^a   Zavoral, M ^a,b   Fric, P ^a,b   Bencko, V ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Central Army Hospital

Author keywords

Colorectal cancer; Faecal occult blood testing; General practitioner; Primary care; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL ASSESSMENT; COLONOSCOPY; COLORECTAL CANCER; COMMUNITY PROGRAM; COMORBIDITY; CZECH REPUBLIC; EUROPE; FECES ANALYSIS; FEMALE; FUNDING; GENERAL PRACTICE; GERMANY; GROUPS BY AGE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OCCULT BLOOD; PATIENT COMPLIANCE; PATIENT MONITORING; POLAND; POPULATION; PRIMARY MEDICAL CARE; SLOVAKIA; CLINICAL PRACTICE; COLORECTAL TUMOR; MASS SCREENING; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; SIGMOIDOSCOPY;

COLORECTAL NEOPLASMS; CZECH REPUBLIC; EUROPE; GUIDELINE ADHERENCE; HUMANS; MASS SCREENING; OCCULT BLOOD; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; SIGMOIDOSCOPY;

EID: 48049086363     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. FERLAY J, BRAY F, PISANI P, PARKIN DM. GLOBOCAN 2002: Cancer Incidence. Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0., Lyon: IARC Press 2004.
2. BERRINO F, CAPOCACCIA R, ESTEVE J et al. Survival of Cancer Patients in Europe: the EUROCARE-2 study. IARC Scientific Publications No 151, Lyon, France 1999.
3. LIGNINE M, RICH M, TEUTECH S et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US preventive services task force. Ann Intern Med 2002; 137: p.132-141. (Pubitemid 34779159)
4. RANSHOFF DF. Colon cancer screening in 2005: status and challenges. Gastroenterology 2005; 128: p.1685-1695.
5. ARAGHIZADEH FY, TIMMCKE AE, OPELAK FG et al. Colonoscopic perforations. Dis Colon rectum 2001; 44: 713-716.
6. LIEBERMANN DA, WEISS DG, BOND JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Copperative Study Group 380, N Engl J Med 2000; 343: 162-166.
7. ATKIN WS, COOK CF, CUZICK J et al. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trila.Lancet 2002; 359: p.1291-1300.
8. TOWLER BP, IRWIG L, GLASZIOU P et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998; 317: 559-565.
9. BOND J. fecal occult blood test screening for colorectal cancer. Gastrointest Endosc Clin North America 2002;12:p.11-21. (Pubitemid 34072777)
10. BOND J. The place of Fecal Occult Blood Test in Colorectal Cancer Screening in 2006: The U.S. perspective. Am J Gastroenterol 2006; 101: 219-221.
11. STEELE JC. Fecal Occult Blood Test Screening in the United Kingdom. Am J Gastroenterol 2006; 101: 216-218. (Pubitemid 43381657)
12. SUNG J. Does Fecal Occult Blood test Have a Place for Colorectal Cancer Screening in China in 2006? Am J Gastroenterol 2006; 101: 213-215. (Pubitemid 43381656)
13. Gastrintestinal Cancers in Europe in: The Burden of Gastrointestinal Diseases in Europe, Public Affairs Committee, UEGF, 2003.
14. SPICAK J, WOHL P, PETRTYL J et al. The national screening programme based on FOBT: the yield of colonoscopy. Endoscopy, in press.
15. ROBINSON MHE, HARDCASTLE JD, MOSS SM et al. The risks of screening: data from Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999; 45: 588-589.
16. COLOMBO L, CORTI G, MAGRI F et al.Results of a pilot study of endoscopic screening of first degree relatives of colorectal patinents in Italy.J Epidem Comm Hlth 1997; 51: 423-458
17. LINDHOLM E, BERGLUND B, KEWENTER J et al. Worry associated with screening of colorectal carcinomas. Scand J Gastroenterol 1997; 32: 238-245
18. FISHER DA, JUDD L, SANFORD NS. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol 2005; 100: 2526-2530 (Pubitemid 43919687)
19. NADEL MR, SHAPIRO JA, KLABUNDE et al. A national survey of primary care physicians' methods for faecal occult blood. Ann Intern Med 2005; 142: 86-94.
20. FRIC P, ZAVORAL M, DVORAKOVA et al. An adapted programme of colorectal cancer screening - 7 years experience and cost-benefit analysis. Hepatogastroenterol 1994; 41: 413-416.
21. ZAVORAL M., ZAVADA F, FRIC P. The Czech national programme of secondary prevention of colorectal cancer. (in Czech, English summary) Ces a Slov.Gastroent Hepatol 2005; 59: s.7-12 (In Czech).
22. ZAVORAL M, ZÁVADA F, ŠÁLEK C, FRIČ P. Czech Society of Gastroenterology: Colorectal Cancer Screening in the Czech Republic, Endoscopy 2006; 38: 550-551.
23. DENIS B, PERRIN P, BELIN J et al. First results of a pilot population-based faecal occult blood colorectal cancer screening programme.UEGW 2005. Gut 2005: 54 (Suppl VII): p.A246.
24. SEIFERT B, HERBER O. The role of General practitioners in colorectal cancer screening. In: Improving patient care in primary care in Europe, EQuiP, NHG 2004, ISBN 90-5793-175-3, p. 44-49.
25. SEIFERT B. Eligibility for colorectal cancer screening with fecal occult blood testing in patients registered in general practice (in Czech, summary in English) Čes a Slov Gastroent a Hepatol 2005; 59), 105-107 (In Czech).